Diagnostic accuracy of interleukin 32γ for tuberculous pleural effusion.

IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM
Journal of thoracic disease Pub Date : 2025-04-30 Epub Date: 2025-04-16 DOI:10.21037/jtd-24-1676
Qi Wang, Li Ma, Kan Zhai, Feng-Shuang Yi, Huan-Zhong Shi, Ming-Ming Shao
{"title":"Diagnostic accuracy of interleukin 32γ for tuberculous pleural effusion.","authors":"Qi Wang, Li Ma, Kan Zhai, Feng-Shuang Yi, Huan-Zhong Shi, Ming-Ming Shao","doi":"10.21037/jtd-24-1676","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Accurate diagnosis of tuberculous pleural effusion (TPE) with biomarkers remains difficult. Interleukin 32gamma (IL-32γ) is a recently discovered proinflammatory cytokines which plays a vital role in the immune response to TPE. This study aimed to assess the diagnostic accuracy of IL-32γ for TPE, especially in different ages of patients.</p><p><strong>Methods: </strong>Patients with a confirmed diagnosis of pleural effusion were systematically recruited from Beijing Chao-Yang Hospital between June 2019 and May 2022. The concentration of IL-32γ and interferon-gamma (IFN-γ) were evaluated in the pleural effusions with different etiology from 188 patients using enzyme-linked immunosorbent assay method. Adenosine deaminase (ADA) was determined by peroxidase method.</p><p><strong>Results: </strong>At a threshold value of 181.56 ng/L, IL-32γ demonstrated an area under the curve (AUC) of 0.812 [95% confidence interval (CI): 0.748-0.865], with sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), positive predictive value (PPV), and negative predictive value (NPV) of 70.2%, 86.0%, 5.0, 0.4, 92.0%, and 55.7%, respectively. In elderly patients (aged >65 years), IL-32γ demonstrated an AUC of 0.984 (95% CI: 0.891-1.000). Notably, the diagnostic accuracy of IL-32γ was significantly higher than that of ADA (P=0.03) and IFN-γ (P=0.02). Similarly, the AUCs for IL-32γ combined with ADA (0.981, 95% CI: 0.886-1.000) and IL-32γ combined with IFN-γ (1.000, 95% CI: 0.920-1.000) were significantly higher than those of ADA (P=0.04) or IFN-γ (P=0.01) alone in elderly patients.</p><p><strong>Conclusions: </strong>IL-32γ can be used as a valuable biomarker for identifying patients with TPE, especially in elderly patients aged >65 years.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"17 4","pages":"2339-2349"},"PeriodicalIF":2.1000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12090101/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of thoracic disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/jtd-24-1676","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/16 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Accurate diagnosis of tuberculous pleural effusion (TPE) with biomarkers remains difficult. Interleukin 32gamma (IL-32γ) is a recently discovered proinflammatory cytokines which plays a vital role in the immune response to TPE. This study aimed to assess the diagnostic accuracy of IL-32γ for TPE, especially in different ages of patients.

Methods: Patients with a confirmed diagnosis of pleural effusion were systematically recruited from Beijing Chao-Yang Hospital between June 2019 and May 2022. The concentration of IL-32γ and interferon-gamma (IFN-γ) were evaluated in the pleural effusions with different etiology from 188 patients using enzyme-linked immunosorbent assay method. Adenosine deaminase (ADA) was determined by peroxidase method.

Results: At a threshold value of 181.56 ng/L, IL-32γ demonstrated an area under the curve (AUC) of 0.812 [95% confidence interval (CI): 0.748-0.865], with sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), positive predictive value (PPV), and negative predictive value (NPV) of 70.2%, 86.0%, 5.0, 0.4, 92.0%, and 55.7%, respectively. In elderly patients (aged >65 years), IL-32γ demonstrated an AUC of 0.984 (95% CI: 0.891-1.000). Notably, the diagnostic accuracy of IL-32γ was significantly higher than that of ADA (P=0.03) and IFN-γ (P=0.02). Similarly, the AUCs for IL-32γ combined with ADA (0.981, 95% CI: 0.886-1.000) and IL-32γ combined with IFN-γ (1.000, 95% CI: 0.920-1.000) were significantly higher than those of ADA (P=0.04) or IFN-γ (P=0.01) alone in elderly patients.

Conclusions: IL-32γ can be used as a valuable biomarker for identifying patients with TPE, especially in elderly patients aged >65 years.

白细胞介素32γ对结核性胸腔积液的诊断准确性。
背景:用生物标志物准确诊断结核性胸腔积液(TPE)仍然很困难。白细胞介素32γ (IL-32γ)是最近发现的促炎细胞因子,在TPE的免疫应答中起重要作用。本研究旨在评估IL-32γ对TPE的诊断准确性,特别是在不同年龄的患者中。方法:系统招募2019年6月至2022年5月在北京朝阳医院确诊的胸腔积液患者。应用酶联免疫吸附法测定188例不同病因胸腔积液中IL-32γ和干扰素γ (IFN-γ)的浓度。过氧化物酶法测定腺苷脱氨酶(ADA)。结果:在阈值为181.56 ng/L时,IL-32γ的曲线下面积(AUC)为0.812[95%置信区间(CI): 0.748 ~ 0.865],敏感性、特异性、阳性似然比(PLR)、阴性似然比(NLR)、阳性预测值(PPV)和阴性预测值(NPV)分别为70.2%、86.0%、5.0、0.4、92.0%和55.7%。在老年患者(50 ~ 65岁)中,IL-32γ的AUC为0.984 (95% CI: 0.891 ~ 1.000)。值得注意的是,IL-32γ的诊断准确率显著高于ADA (P=0.03)和IFN-γ (P=0.02)。同样,老年患者IL-32γ联合ADA (0.981, 95% CI: 0.886-1.000)和IL-32γ联合IFN-γ (1.000, 95% CI: 0.920-1.000)的auc也显著高于单独ADA (P=0.04)或IFN-γ (P=0.01)。结论:IL-32γ可作为鉴别TPE患者的一种有价值的生物标志物,特别是在bb0 ~ 65岁的老年患者中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of thoracic disease
Journal of thoracic disease RESPIRATORY SYSTEM-
CiteScore
4.60
自引率
4.00%
发文量
254
期刊介绍: The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 2.365 for the year 2016. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信